Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Denileukin Diftitox bulk supplier for pharma manufacturers

Denileukin Diftitox 300 mcg Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 300 mcg

Reference Brands: Lymphir (USA/EU), Ontak (USA/EU)

Category: Oncology Cancer Care

Denileukin diftitox is a recombinant fusion protein combining human interleukin‑2 with fragments of diphtheria toxin. It selectively binds to IL‑2 receptors on malignant T-cells and delivers the toxin to kill these cells. It is used to treat adults with relapsed or refractory Cutaneous T‑cell Lymphoma (CTCL) and requires careful monitoring due to potential serious side effects such as infusion reactions, capillary leak syndrome, and liver toxicity.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Denileukin Diftitox — third party manufacturing & bulk supply

Denileukin Diftitox 300 mcg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Denileukin Diftitox listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Denileukin Diftitox →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Denileukin diftitox is used to treat adults with persistent or recurrent cutaneous T‑cell lymphoma (CTCL), especially in cases that have relapsed or not responded to at least one prior systemic therapy.

It is a recombinant fusion protein combining human interleukin‑2 (IL‑2) with fragments A and B of diphtheria toxin.

The trade names are Ontak and Lymphir.

The currently marketed version, Lymphir, is manufactured by Citius Pharmaceuticals, Inc.

The generic name is denileukin diftitox.

Brand names are Ontak and Lymphir.

It is produced in an E. coli expression system under Good Manufacturing Practice conditions and supplied by Citius Pharmaceuticals.

Related Products

Fruquin 5 Mg (Fruquintinib)

Strength:
5 Mg

Form: Capsules

Reference Brands: Everest Bangladesh altd.

View Details
Vorinostat

Strength:
100 mg

Form: Capsules

Reference Brands: Zolinza (USA/EU), Vornat (India)

View Details
Panobinostat Lactate

Strength:
10 mg, 15 mg, 20 mg

Form: Capsules

Reference Brands: Farydak (USA/EU),

View Details
Gilteritinib

Strength:
40 mg

Form: Tablets

Reference Brands: Xospata (USA/India), LuciGil (Asia)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.